Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins and SARS-CoV-2 disease: Current concepts and possible benefits
Madhu Mary Minz, Manish Bansal, Ravi R. Kasliwal
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2063-2067
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis
Amir Vahedian‐Azimi, Seyede Momeneh Mohammadi, Farshad Beni, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 3, pp. 579-595
Open Access | Times Cited: 75
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 6, pp. 101220-101220
Open Access | Times Cited: 49
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
Kuan‐Sheng Wu, Pei‐Chin Lin, Yao-Shen Chen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 874-884
Open Access | Times Cited: 42
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115321-115321
Open Access | Times Cited: 17
Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data
Kyunghee Lee, Jieun Hwang
Archives of Public Health (2025) Vol. 83, Iss. 1
Open Access
Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial
Hajar Shokri‐Afra, Sudabe Baghery moghadam, Ziaeddin Oladi, et al.
Journal of Reports in Pharmaceutical Sciences (2025) Vol. 13, Iss. 1
Open Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial
Hernando Gaitán-Duarte, Carlos Álvarez, Carlos Rincón, et al.
EClinicalMedicine (2021) Vol. 43, pp. 101242-101242
Open Access | Times Cited: 32
Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2
Karsten Grote, Ann-Christin Schaefer, Muhidien Soufi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4522-4522
Open Access | Times Cited: 4
Possible mechanisms of cholesterol elevation aggravating COVID-19
Yan Tang, Longtai Hu, Yi Liu, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 15, pp. 3533-3543
Open Access | Times Cited: 31
The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection
Francisco J. Barrantes
Progress in Lipid Research (2022) Vol. 87, pp. 101166-101166
Open Access | Times Cited: 20
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
Dipanjan Ghosh, Debabrata Ghosh Dastidar, Kamalesh Roy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
Lotfollah Davoodi, Hamed Jafarpour, Ziaeddin Oladi, et al.
IJC Heart & Vasculature (2021) Vol. 36, pp. 100875-100875
Open Access | Times Cited: 25
The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis
Miao Zou, Xiaoyun Su, Luoying Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Therapeutic approaches for SARS-CoV-2 infection
Ankur Gupta, Anish Pradhan, Vimal K. Maurya, et al.
Methods (2021) Vol. 195, pp. 29-43
Open Access | Times Cited: 23
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Wildeman Zapata, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 16
Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities
Yong Xiang, Kenneth Chi-Yin Wong, Hon‐Cheong So
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1514-1514
Open Access | Times Cited: 17
Lipid and Lipoprotein Levels in Patients with COVID-19 Infections
Kenneth R. Feingold
(2020)
Closed Access | Times Cited: 16
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, et al.
Biochimie (2021) Vol. 189, pp. 51-64
Open Access | Times Cited: 15
Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors
Yuji Ikari, Yuya Matsue, Sho Torii, et al.
Circulation Journal (2021) Vol. 85, Iss. 6, pp. 939-943
Open Access | Times Cited: 14
Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID‐19; a retrospective cohort study
Mohammad Haji Aghajani, Omid Moradi, Hamed Azhdari Tehrani, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 9
Open Access | Times Cited: 12
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study
Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7492-7492
Open Access | Times Cited: 5
Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19
Hernando Gaitán-Duarte, Carlos Álvarez, Carlos Rincón, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor
Nesreen F. Alkhofash, Bassam R. Ali
Biomolecules (2024) Vol. 14, Iss. 7, pp. 764-764
Open Access
Page 1 - Next Page

Scroll to top